IGF1 and ovarian cancer: While treatment with IGF promoted the migration, invasion and wound healing of ovarian cancer cells treatment with BAPTA-AM significantly mitigated the IGF-induced migration, invasion and wound healing in both SKOV3 and OVCAR3 cells in vitro (Fig. 5e and f).